Evaluation of safety and efficacy of colon cancer stem cell target immunotherapy

ABSTRACT: Interventions: OR7C1+IFNb BORIS+IFNb OR7C1+IFNa BORIS+IFNa Primary outcome(s): 1) Safety 2) Immunological response Study Design: Parallel Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2649618 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR